Evidence map›Paper›PMID 15944344›Full record

ArticleGenetics2005

Systematic segregation to mutant mitochondrial DNA and accompanying loss of mitochondrial DNA in human NT2 teratocarcinoma Cybrids.

Carrie J Turner, Caroline Granycome, Rachel Hurst, Elizabeth Pohler, M Katariina Juhola, Martti I Juhola, Howard T Jacobs, Lesley Sutherland, Ian J Holt

Abstract read
In one paragraph

Article in Genetics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Mitochondria and cancer: past, present, and future.BioMed research international · 2013
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Mitochondrial regulation of cancer associated nuclear DNA methylation.Biochemical and biophysical research communications · 2007
    Article
  13. Single-cell A3243G mitochondrial DNA mutation load assays for segregation analysis.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2007
    Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carrie J TurnerMRC Dunn Human Nutrition Unit, Wellcome Trust, Cambridge CB2 2XY, United Kingdom.
Caroline Granycome
Rachel Hurst
Elizabeth Pohler
M Katariina Juhola
Martti I Juhola
Howard T Jacobs
Lesley Sutherland
Ian J Holt

Funding

Medical Research Council MC_U105663140Wellcome Trust
6 · The paper itself

Abstract

In this study a well-characterized pathological mutation at nucleotide position 3243 of human mitochondrial DNA was introduced into human rho(0) teratocarcinoma (NT2) cells. In cloned and mixed populations of NT2 cells heteroplasmic for the mutation, mitotic segregation toward increasing levels of mutant mitochondrial DNA always occurred. Rapid segregation was frequently followed by complete loss of mitochondrial DNA. These findings support the idea that pathological mitochondrial DNA mutations are particularly deleterious in specific cell types, which can explain some of the tissue-specific aspects of mitochondrial DNA diseases. Moreover, these findings suggest that mitochondrial DNA depletion may be an important and widespread feature of mitochondrial DNA disease.

Indexed as

MutationCell Line, TumorClone CellsDNA, MitochondrialHumansHybrid CellsKineticsMitosisTeratocarcinomaTime FactorsDNA, Mitochondrial

Identifiers

PMID15944344
PMCPMC1449769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.